Skip to content
Use caution Drug recall · FDA · Published October 16, 2014

Apotex Recalls Candesartan Cilexetil 4mg Tablets Due to Impurities

Apotex Inc. recalls specific lots of Candesartan Cilexetil 4mg tablets due to failed impurity specifications. Check your bottle's lot number and expiration date.

🇺🇸 FDA recall #D-0241-2015DrugApotex ›
Take action

Contact the company

Recalling firmApotex Inc.150 Signet Drive · Toronto, Canada
✎ GovInfoNow plain-language explainer

Apotex Inc. is recalling a small quantity of Candesartan Cilexetil Tablets, 4 mg, because they contain out-of-specification levels of certain impurities. The affected bottles were manufactured by Apotex Research Pvt. Ltd. in India and distributed nationwide. No specific remedy or return instructions are provided in the record. Read more at govinfonow.com/recall/45651-apotex-inc-recalls-candesartan-cilexetil-tablets-4-mg-30-count.

Source Summary by GovInfoNow · govinfonow.com/recall/45651-apotex-inc-recalls-candesartan-cilexetil-tablets-4-mg-30-count · Updated October 12, 2026 · FDA enforcement record: FDA #D-0241-2015

Cite this page

“Apotex Recalls Candesartan Cilexetil 4mg Tablets Due to Impurities.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/45651-apotex-inc-recalls-candesartan-cilexetil-tablets-4-mg-30-count. Based on FDA recall #D-0241-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0241-2015%22&limit=1).

The FDA announced on 2014-10-16 that Apotex Inc. is recalling Candesartan Cilexetil Tablets, 4 mg, due to failed impurity specifications. The agency stated the recall was voluntary and initiated by the firm.

How to tell if you have it

  • Brand: Apotex
  • Product: Candesartan Cilexetil Tablets 4 mg
  • Packaging: 30-count bottle, Rx Only
  • NDC: 60505-3618-3
  • Lot codes: KR3924, KR3926
  • Expiration date: 11/15
  • Manufacturer: Apotex Research Pvt. Ltd., Bangalore-560 099, India
  • Distributor: Nationwide
  • Units affected: 13,177 bottles

The hazard

The recall addresses out-of-specification results for CAD-II, CAD-V, and Total Impurities in the tablets. The FDA classified this as a Class III recall.

Context

GovInfoNow's records show Apotex Inc. has 19 other recalls on record since 2020-05-27. Other recent recalls of similar products include Apotex Metformin Tablets Recall (2020-05-27), Apotex Atorvastatin 40mg Tablets Recall (2019-10-22), and Apotex Rite Aid Maximum Strength Ranitidine Tablets Recall (2019-09-24). Additional recent recalls include Apotex Paxil CR 37.5mg Tablets Recall (2026-08-13), Apotex Recalls Paroxetine 37.5mg Due to Dissolution Failure (2026-09-23), and Cipla Recalls Fosfomycin Tromethamine Granules Due to Impurities (2026-09-18).

How to tell if you have this one

Check your medication bottle for the following details: Brand: Apotex; Product: Candesartan Cilexetil Tablets, 4 mg, 30-count bottle; NDC: 60505-3618-3. Affected Lot Numbers are KR3924 and KR3926. The expiration date is 11/15.

  • Brand
    Apotex
  • Category
    Drug
FDA recall event · 4 products

All 4 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class III
  • Status
    Terminated
  • Distribution
    Nationwide.
Recall numberProduct, codes & lotsQuantity
D-0241-2015Candesartan Cilexetil Tablets, 4 mg, 30-count bottle, Rx Only, Manufactured by Apotex Research Pvt. Ltd., Bangalore- 560 099, India, Manufactured for Apotex Corp., Weston, FL 33326, NDC 60505-3618-3; Lot #: KR3924, KR3926; Exp. 11/1513,177 bottles
D-0242-2015Candesartan Cilexetil Tablets, 8 mg, 30-count bottle, Rx Only, Manufactured by Apotex Research Pvt. Ltd., Bangalore- 560 099, India, Manufactured for Apotex Corp., Weston, FL 33326, NDC 60505-3619-3; Lot # KR3933; Exp.10/15 Lot # KR3935, KR3934; Exp.11/1518,493
D-0243-2015Candesartan Cilexetil Tablets, 16 mg, a) 30-count bottle (NDC 60505-3620-3) b) 90-count bottles (NDC 60505-3620-9) Rx Only, Manufactured by Apotex Research Pvt. Ltd., Bangalore- 560 099, India, Manufactured for Apotex Corp., Weston, FL 33326; Lot #: a) KR3943; Exp. 11/15 Lot #: b) KT6058, KT6060; Exp. Date 11/1511,062 bottles
D-0244-2015Candesartan Cilexetil Tablets, 32 mg, a) 30-count bottle (NDC 60505-3621-3) b) 90-count bottles (NDC 60505-3621-9) Rx Only, Manufactured by Apotex Research Pvt. Ltd., Bangalore- 560 099, India, Manufactured for Apotex Corp., Weston, FL 33326; Lot #: a) KR3955; Exp. 10/15, KV0430, Exp. 11/15 Lot #: b) KT6063; Exp. 10/1522,710 bottles
Based on the official FDA remedy

What to do — step by step

  1. Check Your Medication

    Verify if your bottle matches the NDC 60505-3618-3 and has Lot Numbers KR3924 or KR3926 with an expiration date of 11/15.

  2. Contact Your Pharmacist

    If you have the affected product, speak with your pharmacist or healthcare provider immediately to discuss replacement options.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 23 months after the firm started it.

1. Firm started the recall: Oct 16, 201412. FDA classified it Class III: Nov 6, 201423. Published in FDA’s Enforcement Report: Nov 12, 201434. FDA terminated the recall: Sep 30, 2016420142016
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

How many bottles are being recalled?

Approximately 13,177 bottles are included in this recall.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0241-2015 (October 16, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0241-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA